[Recent advance in polymyositis and dermatomyositis research]

Area of Science:

• Immunology
• Pathogenesis of inflammatory myopathies

Context:

• Current understanding of dermatomyositis (DM) and polymyositis (PM) pathogenesis, involving CD4 T cells, humoral immunity, and cytotoxic T cells, is being re-evaluated.
• Skeletal muscle C-protein has been identified as a potent immunogen capable of inducing experimental myositis that resembles human polymyositis.
• While antibodies to aminoacyl tRNA synthases are observed in PM/DM patients, they are more prevalent in cases of interstitial pneumonitis.

Purpose:

• To challenge the existing paradigms in the pathogenesis of inflammatory myopathies.
• To explore potential autoantigens and their role in inducing myositis.
• To investigate the involvement of inflammatory cytokines and their therapeutic potential.

Summary:

• The established view of muscle tissue injury in DM (CD4 T cells, humoral immunity) and PM (cytotoxic T cells) is being questioned.
• Experimental models using skeletal muscle C-protein successfully mimicked human polymyositis, highlighting its potential as an autoantigen.
• The role of inflammatory cytokines, including tumor necrosis factor alpha, in autoimmune myositis pathogenesis is complex and requires further investigation, with potential for future therapeutic targeting.

Impact:

• Suggests a need for revised understanding of inflammatory myopathy mechanisms.
• Identifies skeletal muscle C-protein as a key factor in experimental myositis.
• Highlights the complex role of cytokines and points towards new therapeutic strategies for autoimmune muscle diseases.